Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...
Researchers simulated nearly every molecule in a bacterial cell — and then watched the cell grow and reproduce.
Morning Overview on MSN
CRISPR approach targets mitochondria to aid heart failure treatment
Rice University researchers have developed a CRISPR-based gene activation strategy that boosts mitochondrial production in damaged heart cells, improving cardiac function after heart attacks in both ...
Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...
Chinese scientists create modified fungus that tastes like meat, produces protein quickly, and uses 70 percent less land.
A 19-year-old Canadian man becomes the first human cured through prime gene editing after doctors corrected a rare genetic ...
A Texas biotech company is trying to bring mammoths and other extinct creatures back to life. The science is as intriguing as the ethical questions are thorny.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results